Published ahead of print on June 23, 2005, doi:10.1164/rccm.200503-458OC
Am. J. Respir. Crit. Care Med., Volume 172, Number 7, October 2005, 831-836
A more recent version of this article appeared on October 1, 2005
Submitted on March 22, 2005
Accepted on June 17, 2005
Titrating Steroids on Exhaled Nitric Oxide in Asthmatic Children: a Randomized Controlled Trial
Marielle W Pijnenburg1*, E. Marije Bakker1, Wim C Hop2, and Johan C De Jongste1
1 Department of Pediatric Respiratory Medicine, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands,
2 Department of Epidemiology and Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands
* To whom correspondence should be addressed. E-mail: m.pijnenburg{at}erasmusmc.nl.
Rationale: Corticosteroids are the anti-inflammatory treatment of choice in asthma. Treatment guidelines are mainly symptom-driven but symptoms are not closely related to airway inflammation. Nitric oxide in exhaled air (FeNO) is a marker of airway inflammation in asthma.
Objective: We evaluated whether titrating steroids on FeNO improved asthma management in children.
Methods: Eighty-five atopic asthmatic children using inhaled steroids were allocated to a FeNO group (n=39), where treatment decisions were made on both FeNO and symptoms, or in a symptom group (n=46), treated on symptoms only. Children were seen every 3 months during 1 year.
Measurements: Symptoms were scored during 2 weeks before visits and 4 weeks before the final visit. FeNO was measured at all visits, and airway hyperresponsiveness and Forced Expiratory Volume in 1 second (FEV1) at start and end of the study. Primary endpoint was cumulative steroid dose.
Results: Changes in steroid dose from baseline did not differ between groups. In the FeNO group, hyperresponsiveness improved more than in the symptom
group (2.5 vs 1.1 doubling dose, p=0.04). FEV1 in the FeNO-group improved, the change in FEV1 was not significantly different between groups. The FeNO group had 8 severe exacerbations versus 18 in the symptom group. The change in symptom scores did not differ between groups. FeNO increased in the symptom group; the change in FeNO from baseline differed between groups (p=0.02).
Conclusion: In asthmatic children, 1 year of steroid titration on FeNO did not result in higher steroid doses and improved airway hyperresponsiveness and - inflammation.
Key words: corticosteroids, lung function, symptoms, airway hyperresponsiveness, treatment
This article has been cited by other articles:

|
 |

|
 |
 
M. Malerba, B. Ragnoli, A. Radaeli, and C. Tantucci
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma
Chest,
October 1, 2008;
134(4):
733 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lara, S. B. Khatri, Z. Wang, S. A. A. Comhair, W. Xu, R. A. Dweik, M. Bodine, B. S. Levison, J. Hammel, E. Bleecker, et al.
Alterations of the Arginine Metabolome in Asthma
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
673 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Taylor, E. D. Bateman, L-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, J. C. de Jongste, et al.
A new perspective on concepts of asthma severity and control
Eur. Respir. J.,
September 1, 2008;
32(3):
545 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Latzin and U. Frey
Environmental exposure in relation to exhaled nitric oxide in newborns: is it all about timing?
Eur. Respir. J.,
August 1, 2008;
32(2):
252 - 254.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med.,
May 15, 2008;
177(10):
1068 - 1073.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Lim and C. Mottram
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest,
May 1, 2008;
133(5):
1232 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bodini, D. Peroni, A. Loiacono, S. Costella, R. Pigozzi, E. Baraldi, A. L. Boner, and G. L. Piacentini
Exhaled Nitric Oxide Daily Evaluation Is Effective in Monitoring Exposure to Relevant Allergens in Asthmatic Children
Chest,
November 1, 2007;
132(5):
1520 - 1525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nuijsink, W. C. J. Hop, P. J. Sterk, E. J. Duiverman, J. C. de Jongste, and on behalf of the Children Asthma Therapy Optimal (
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Eur. Respir. J.,
September 1, 2007;
30(3):
457 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Shaw, M. A. Berry, M. Thomas, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord
The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Turner, L. C. A. Craig, P. J. Harbour, S. H. Forbes, S. Martindale, G. McNeill, A. Seaton, J. G. Ayres, G. Devereux, and P. J. Helms
Carbonated drink consumption and increased exhaled nitric oxide in atopic children
Eur. Respir. J.,
July 1, 2007;
30(1):
177 - 178.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Menzies, A. Nair, and B. J. Lipworth
Portable Exhaled Nitric Oxide Measurement: Comparison With the "Gold Standard" Technique
Chest,
February 1, 2007;
131(2):
410 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Spencer
A paper that changed my practice: S McKenzie. Cough but is it asthma? Arch Dis Child 1994;70:1-2
Arch. Dis. Child.,
January 1, 2007;
92(1):
82 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lex, F. Ferreira, A. Zacharasiewicz, A. G. Nicholson, P. L. Haslam, N. M. Wilson, T. T. Hansel, D. N. R. Payne, and A. Bush
Airway Eosinophilia in Children with Severe Asthma: Predictive Values of Noninvasive Tests
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1286 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Latzin, C. E. Kuehni, D. N. Baldwin, H. L. Roiha, C. Casaulta, and U. Frey
Elevated Exhaled Nitric Oxide in Newborns of Atopic Mothers Precedes Respiratory Symptoms
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1292 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pijnenburg
Exhaled nitric oxide in childhood asthma: methodological issues and clinical applications
Eur. Respir. Rev.,
December 1, 2006;
15(101):
215 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste
Exhaled nitric oxide measurements: clinical application and interpretation
Thorax,
September 1, 2006;
61(9):
817 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Hargreave and K. Parameswaran
Asthma, COPD and bronchitis are just components of airway disease.
Eur. Respir. J.,
August 1, 2006;
28(2):
264 - 267.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kelso
Titrating Steroids on Exhaled Nitric Oxide in Children With Asthma: A Randomized, Controlled Trial
Pediatrics,
August 1, 2006;
118(Supplement_1):
S33 - S33.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
6 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. van Veen, P. J. Sterk, R. Schot, S. A. Gauw, K. F. Rabe, and E. H. Bel
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Eur. Respir. J.,
May 1, 2006;
27(5):
951 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J L Heraghty and A J Henderson
Highlights in asthma 2005.
Arch. Dis. Child.,
May 1, 2006;
91(5):
422 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
698 - 706.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Brightling
Sputum Induction in Asthma
Chest,
March 1, 2006;
129(3):
503 - 504.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|